# CSL Limited

Type: Company (CSL.AX)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/csl-limited
Canonical HTML page: https://getbiobrief.com/entity/csl-limited

## Timeline

- **2026-03-24**: Agreement Signed — Landmark FTA officially signed, initiating the ratification process.
- **2025-01-15**: Strategic Pivot — Talks resume with a new focus on critical minerals and supply chain security.
- **2023-10-29**: Talks Stall — Negotiations collapse in Osaka over agricultural quotas and geographic indications.
- **2018-06-18**: Negotiations Launched — Formal trade talks begin in Canberra focusing on market access and IP.

## Recent coverage (1 stories)

### EU-Australia Free Trade Deal Unlocks New Pharma and MedTech Corridors
2026-03-24 14:06:32 · Sentiment: Positive · Impact: 7/10 · Sources: 2

After eight years of complex negotiations, the European Union and Australia have signed a landmark free trade agreement aimed at eliminating regulatory barriers. The deal is set to streamline market access for European biologics while securing critical mineral supply chains essential for advanced medical manufacturing.
Full story: https://getbiobrief.com/story/eu-australia-free-trade-agreement-pharma-impact

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.